Participant flow24

How many started, completed or left each group, period by period.

1 to 20 of 24

Period	Milestone	Group	Participants
Randomized Phase	STARTED	SEL 18 mg	355
Randomized Phase	STARTED	SEL 6 mg	354
Randomized Phase	STARTED	Placebo	174
Randomized Phase	STARTED	Open-Label SEL 18 mg	0
Randomized Phase	COMPLETED	SEL 18 mg	0
Randomized Phase	COMPLETED	SEL 6 mg	0
Randomized Phase	COMPLETED	Placebo	0
Randomized Phase	COMPLETED	Open-Label SEL 18 mg	0
Randomized Phase	NOT COMPLETED	SEL 18 mg	355
Randomized Phase	NOT COMPLETED	SEL 6 mg	354
Randomized Phase	NOT COMPLETED	Placebo	174
Randomized Phase	NOT COMPLETED	Open-Label SEL 18 mg	0
Open-Label Phase	STARTED	SEL 18 mg	0
Open-Label Phase	STARTED	SEL 6 mg	0
Open-Label Phase	STARTED	Placebo	0
Open-Label Phase	STARTED	Open-Label SEL 18 mg	23
Open-Label Phase	COMPLETED	SEL 18 mg	0
Open-Label Phase	COMPLETED	SEL 6 mg	0
Open-Label Phase	COMPLETED	Placebo	0
Open-Label Phase	COMPLETED	Open-Label SEL 18 mg	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03053063/flow